Bioorganic & Medicinal Chemistry Letters
Publisher: Elsevier · ISSN 0960-894X · 37 articles
- Mapping of Ligandable tyrosine and lysine residues in proteins implicated in mitochondrial DNA depletion and therapeutic relevance
- Structure–activity relationship optimization of ML221-derived non-peptide Apelin receptor antagonists with anti-angiogenic activity
- Editorial Board
- Quinolin(on)es and pyridin(on)es as promising scaffolds against mycobacterial infections
- Synthesis and antimalarial activity of novel C30-aminated betulin derivatives
- Reactivation of an inert 15-mer antimicrobial peptide by truncation-directed i, i + 7 lactam cyclization
- Semi-synthesis and activity study of α-mangostin ether derivatives bearing N-heterocyclic side chains as multitarget-directed ligands against AD
- Efficient PNA double-duplex invasion using preQ1•G-clamp as a pseudo-complementary G•C base pair
- 6-(2-Hydroxybenzoyl)pyrazolo[1,5-a]pyrimidine-3‑carbonitriles as novel reactive oxygen species-generating anticancer agents inducing ER stress and DNA damage in EGFR-mutant non-small cell lung cancer
- Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer
- Amyloid-β aggregation inhibitory activity and neuroprotective effects of metabolites of Trichoderma pluripenicillatum
- Discovery of potent, selective, and orally bioavailable monocyclic pyridine-based PKMYT1 inhibitors that synergize with CHK1 inhibition in replication-stressed cancer cells
- Electrophilic aromatic halogenation of perylenequinones: a strategy to improve photodynamic properties
- Synthesis and discovery of polyisopentenylated acylphloroglucinols with selective antiproliferative activity against breast cancer cells
- Discovery of Fisetin as a potent and cell-active ACVR2A inhibitor
- Photocaging of a GPR52 agonist enables light-dependent receptor activation in cells
- The antiproliferative and pro-apoptotic effects of 3-deoxy-3α-fluoro-chenodeoxycholic acid and 12β-methyl-3,7-dioxo-17-epi-25-homo-18-nor-5β-cholan-25-oic acid on human breast cancer cell lines
- Structure-activity profiling of indazole-based derivatives as spinster homolog 2 (Spns2)-dependent S1P release inhibitors
- Discovery of potent GPR120 activators with fatty orosensation enhancement activity
- Discovery and characterization of potent and efficacious small-molecule parathyroid hormone Receptor-1 (PTH1R) antagonists for the treatment of hypercalcemia
- Uncovering the importance of lipofection for aptamer-mediated therapeutic oligonucleotide delivery in a HER2+ SKBR3 breast cancer cell line
- Design, synthesis, and preliminary in vitro screening of novel tolmetin hydrazones against colon cancer
- Structure activity relationship studies of alkynyl 6-nitroquinoxalines as potential anti-tuberculosis agents
- Synthesis and pharmacological evaluation of a series of fluoro-substituted 3-phenoxy-azetidines as cortical enhancers for the treatment of apathy
- Contents continued
- Graphical abstract TOC
- V-domain immunoglobulin suppressor of T-cell activation (VISTA) immune checkpoint: a medicinal chemistry perspective
- Benzothiazoloquinolines as protease-activated receptor 4 (PAR4) antagonists with excellent rat pharmacokinetic properties
- Drug repurposing-inspired design of miconazole-based 1,2,3-triazoles as antichagasic agents
- Design, synthesis, and biological evaluation of 4H-pyran-4-one-based CYP11A1 inhibitors